Prostate cancer (CaP) is the most common non--cutaneous cancer in men.
• Treatment options include Surgery (Radical Prostatectomy), External Beam Radiation, Brachytherapy, and Hormonal Therapy
• Monitoring of PSA after treatment leads to identiDication of patients with PSA-only recurrence (biochemical failure) who are otherwise asymptomatic.
• Detecting isolated local recurrences that can be cured with salvage treatment is a current challenge.
Hybrid PET/MRI
• The use of positron emission tomography (PET) with radiolabeled choline analogues has shown promise in detection of prostate cancer (CaP) recurrence after deDinitive local therapy. 1--2 • Magnetic Resonance Imaging (MRI) is increasingly used for CaP staging, and has superior soft--tissue resolution and options for multi--parametric and functional imaging. 3 • The simultaneous use of PET and MRI has been enabled by a new generation of hybrid PET/MRI scanners. 3 
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• 18 F-FCH PET/MRI shows promise for men with suspected prostate cancer recurrence following RP or RT. • PET/MRI findings had impact on clinical management.
• When there was a change in management decision, PET/MRI had a relatively high degree of influence. The influence was more significant in the RP than in the RT cohort.
Hybrid PET/MRI
PET/MRI were acquired as follows:
• T2W MRI and PET of the pelvis with body--array coil 1. To examine the feasibility of 18 F--FCH hybrid PET/MRI through a pilot study for evaluating men with suspected CaP recurrence being considered for local salvage therapies after initial radical prostatectomy (RP) or radical radiotherapy (RT).
2.
To investigate the impact of 18 F--FCH PET/MRI Dindings on clinical management.
F-Fluorocholine ( F-FCH)
Choline analogues:
• Altered choline metabolism characteristic of prostate cancer; changes in choline uptake/retention A pa4ent with suspected local recurrence a[er defini4ve RT. He originally had biopsy--proven disease at the Right base and received RT 79Gy in 39 frac4ons. Subsequently presented with biochemical failure, PSA 6 at 4me of imaging. Images show MRI changes at the right base (low T2 and ADC), with increased fluorocholine uptake. Re--biopsy of this area confirmed recurrent cancer.
